Dabrafenib inhibits the growth of BRAF‐WT cancers through CDK16 and NEK9 inhibition

Publisher: John Wiley & Sons Inc

E-ISSN: 1878-0261|12|1|74-88

ISSN: 1574-7891

Source: Molecular Oncology, Vol.12, Iss.1, 2018-01, pp. : 74-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract